About Merantix Capital
Merantix Capital is a venture capital firm founded in 2016. It is primarily based out of Berlin, Germany. As of Jun 2026, Merantix Capital is an active investor, having invested in 16 companies, with 3 new investments in the last 12 months. It primarily invests in Seed round in Germany based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and High Tech. Most recently it participated in the $***** Series A round of Almetra Overall, Merantix Capital portfolio has seen 3 acquisitions, namely Libra and Kausa. A lot of funds co-invest with Merantix Capital, with names like Robin Capital sharing a substantial percentage of its portfolio. Merantix Capital has team of 18 people including 9 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Rounds of Entry
Seed & Series A
Deals in last 12 months
Merantix Capital's List of Top Investments
Merantix Capital has a portfolio of 16 companies. Their most notable investments are in droidrun.ai and Outpost Bio.Their portfolio spans across Germany, Austria, Switzerland and 1 more locations. They have invested in Enterprise Applications, HealthTech, High Tech and 7 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Merantix Capital:
1. Vara
Provider of AI-based breast cancer screening software for clinics. It detects normal mammograms and flags according to their severity. It develops reports according to the findings of the platform. It can be integrated with RIS and PACS software.
Key facts about Vara
- Founded Year: 2016
- Location: Berlin (Germany)
- Stage: Series A
- Total Funding till date: $20.3M
- Employee Count: 54 as on Sep 30, 2026
- Investors: EQT, Think.Health and 12 Others
- Latest Funding Round: Series A, Oct 29, 2024, $*****
- Highlight: Editors' Pick
Provider of AI-based precision immunology technology to develop targeted therapies and biomarkers for immune-driven diseases. It uses primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies & biomarkers for immune-driven diseases.
Key facts about Graph Therapeutics
- Founded Year: 2024
- Location: Klosterneuburg (Austria)
- Stage: Series A
- Total Funding till date: $8.1M
- Employee Count: 14 as on Aug 31, 2026
- Investors: SquareOne, Merantix Capital and 5 Others
- Latest Funding Round: Grant (prize money), Jun 22, 2026, $*****
- Highlight: Editors' Pick
3. Libra
AI-powered legal workspace provider for research, drafting, and review. It offers tools to assist with different legal work, including comprehensive legal inquiries via an advanced chat feature with integrated web search and Noxtua integration. The platform facilitates document review and analysis, allowing for processing of files. It offers AI assistants and workflows to streamline tasks, and a word add-in that can be integrated with existing workflows. It is available on a subscription based pricing plan.
Key facts about Libra
- Founded Year: 2023
- Location: Berlin (Germany)
- Stage: Acquired
- Employee Count: 89 as on Aug 31, 2026
- Investors: Merantix Capital and Linden Capital
- Highlight: Acquired
4. revel8
Provider of AI-powered platform for social engineering and phishing attack simulations. The platform offers tools for threat intelligence, risk profiling, and attack simulations across multiple communication channels. It delivers security education with gamified elements and reporting to align with compliance frameworks. The platform aims to build a solid human firewall.
Key facts about revel8
- Founded Year: 2024
- Location: Berlin (Germany)
- Stage: Seed
- Total Funding till date: $8.23M
- Employee Count: 61 as on Aug 31, 2026
- Investors: Merantix Capital, Fortino Capital and 6 Others
- Latest Funding Round: Seed, Sep 25, 2025, $*****
5. Briink
Provider of AI-powered platform for environmental, social, and governance data analysis. The platform extracts, structures, and analyzes data at scale in real time. It automates questionnaires, screening, benchmarking, run gap analyses for compliance, screen suppliers and investments, supports auditors with verification and assurance. It also provides features for asset managers and corporations.
Key facts about Briink
- Founded Year: 2021
- Location: Berlin (Germany)
- Stage: Seed
- Total Funding till date: $4.3M
- Employee Count: 22 as on Sep 30, 2026
- Investors: 13books Capital, Merantix Capital and 3 Others
- Latest Funding Round: Seed, Sep 30, 2024, $*****
- Highlight: Editors' Pick
Merantix Capital's Year-on-Year Investment Trends
In 2025, it made 5 investments, while as of Jun 2026, it has made 3 investments in this year. Its most recent first time investment was in Almetra and most recent follow-on round was in Graph Therapeutics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 1 | 3 |
2025 | 5 | 0 | 5 |
2024 | 4 | 0 | 4 |
Merantix Capital's Investments by Stage
Merantix Capital has made 9 investments in Seed stage with an average round size of $4.15M and 2 investments in Series A stage with an average round size of $13.7M.Stage of entry | No. of Investments |
|---|---|
Seed | 9 |
Series A | 2 |
Note: We have considered here, only first round of investments
Merantix Capital's Investments by Sector
Merantix Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Artificial Intelligence - Industry Applications, HealthTech, Healthcare and Industrial Goods and Manufacturing. Notably, it has invested in 14 Enterprise (B2B) companies, 13 Software companies, 13 Tech companies and at least 7 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 8 |
Artificial Intelligence - Industry Applications | 3 |
HealthTech | 2 |
Healthcare | 2 |
Industrial Goods and Manufacturing | 2 |
Others | 6 |
Note: We have considered here, only first round of investments
Merantix Capital's Investments by Geography
Merantix Capital has made most investments in Germany (7), followed by Austria where it has made 1 investment.Country | No. of Investments |
|---|---|
Germany | 7 |
Austria | 1 |
Switzerland | 1 |
United States | 1 |
Note: We have considered here, only first round of investments
Merantix Capital's recent investments
Merantix Capital has made 3 investments in 2026 so far. Almetra and Graph Therapeutics are the latest among them.Here are the most recent investments by Merantix Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 25, 2026 | Germany | Series A | 2300 | [+4] | |
Jun 22, 2026 | Austria | Series A | 7504 | [+2] | |
Mar 02, 2026 | United States | Seed | 6450 | [+2] | |
Dec 11, 2025 | Germany | Seed | 1812 | ||
Sep 30, 2025 | Switzerland | Seed | 5015 |
Acquired companies in Merantix Capital's Portfolio
3 companies from Merantix Capital's portfolio have been acquired. The most recent acquisition was Libra in Nov 2025 by Wolters Kluwer for $*****.Here are Merantix Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 14, 2025 | - | - | 2503 | |
Sep 01, 2023 | - | - | 4950 | |
Nov 03, 2021 | - | - | 9710 |
_1580300642159.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of Merantix Capital
Merantix Capital has a team of 18 members including 9 Partners and 2 Principals located in Germany and United Kingdom. Merantix Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Merantix Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Berlin | - | ||
Partner | Berlin | - | - | |
Partner | Berlin | - | - | |
Partner | Berlin | - | - | |
Partner | Berlin | - | - | |
Partner | Germany | - | - | |
Partner | Berlin | - | - | |
Partner | Munich | - | - | |
Partner | London | - | - | |
Principal | London | - | - |
Co-investors of Merantix Capital
Over the past 2 years, 51 investors have co-invested in Merantix Capital's portfolio companies. This includes funds and angels.
- Invested before Merantix Capital: VI Partners, Med360 and 7 others have invested in rounds before Merantix Capital. There is 1 company where VI Partners has invested before Merantix Capital and 1 company where Med360 has invested before Merantix Capital.
- Top Co-investors of Merantix Capital: 38 investors entered a company along with Merantix Capital. These include investors like Robin Capital (2 companies).
- Invested after Merantix Capital: A total of 4 investors have invested in Merantix Capital's portfolio after their investments. Top Investors include Austria Wirtschaftsservice (1 company), FFG (1 company) and Daphni (1 company).
Recent News related to Merantix Capital
•
Almetra Raises €16.3M Series A Led by blisce/ to Enhance Factory IntelligenceTech Funding News•Jun 25, 2026•Blisce, NAP, Merantix Capital, Underline and 4 others
•
Graph Therapeutics Raises $5 Million For Inflammation And Immunology ProgramsPulse 2.0•Jun 23, 2026•Graph Therapeutics, Merantix Capital, SquareOne, Daphni
•
WhyBrilliant Raises €1M Pre-Seed for AI Hiring PlatformStartup Researcher•Jun 16, 2026•Merantix Capital
•
•
German VC Merantix Capital closes €103 million fund for early-stage AI startupsEU-Startups•Jun 04, 2026•Merantix Capital
•
Female-led BioTech startup OutPost Bio raises €2.9 million to make human microbiology computableEU-Startups•Mar 02, 2026•Outpost Bio, Merantix Capital, Seedcamp, OpenSeed VC and 1 other
•
FICUS lands €3M to automate docs in Germany’s strained rehab sectorTech Funding News•Dec 11, 2025•Ficus-Health, Redstone, Merantix Capital
•
Swiss AI startup Arqh secures $3.8M to help logistics teams escape spreadsheet chaosTech Funding News•Sep 30, 2025•Merantix Capital, Founderful, Merantix, arqh.ch and 1 other
•
Revel8 secures €7M to transform employees into AI-powered human firewallsTech Funding News•Sep 25, 2025•revel8, Merantix Capital, Fortino Capital, Peak
•
Graph Therapeutics secures $3.1M to disrupt $257B AI-powered inflammation & immunology drug discovery marketTech Funding News•Jan 09, 2025•Graph Therapeutics, Merantix Capital, Atomico, SquareOne
